title: Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study.
abstract: To determine the spectrum of systemic diseases associated with pauci-immune necrotizing crescentic glomerulonephritis, we have analysed extra-renal manifestations, occurrence of extra-glomerular vasculitis and incidence and specificity of antinuclear cytoplasmic antibodies (ANCA) in 40 patients selected only on renal histological criteria. Extra-renal symptoms were unexpectedly observed in all patients but one, and were suggestive of vasculitis in 24. Extra-glomerular vasculitis was seen in 18 kidney biopsies and four biopsies from other organs. Among the 33 patients with suspected or established vasculitis, 13 had presumed or biopsy-proven Wegener's granulomatosis, three had a macroscopic form of polyarteritis nodosa and 17 could not be adequately classified. An additional patient had clinical signs of Wegener's granulomatosis without clinical and histological evidence of vasculitis. ANCAs were detected in 28 of 33 and 25 of 34 sera tested by immunofluorescence and enzyme-linked immunoassay, respectively: 19 contained anti-myeloperoxidase antibodies and six had anti-proteinase 3 activity. Anti-myeloperoxidase and anti-proteinase 3 antibodies were present in all clinical subgroups but with various frequencies: anti-myeloperoxidase antibodies were more common (six of 12) than anti-proteinase 3 (four of 12) in patients with suspected or histologically proven Wegener's granulomatosis. Anti-proteinase 3 antibodies were 3- to 4-fold more common in patients with Wegener's granulomatosis than in those with systemic vasculitis of other causes (one of 12) or necrotizing crescentic glomerulonephritis without evidence of extra-renal vasculitis (one of 10). These results strongly suggest that pauci-immune necrotizing crescentic glomerulonephritis belongs to the broad spectrum of necrotizing vasculitides affecting glomerular capillaries. This study shows substantial improvement in renal prognosis and life expectancy with aggressive immunosuppressive therapy despite the older age of the patients, dissemination of the vasculitic process and often delayed diagnosis.
authors.affiliation: Service de Néphrologie, Hôpital Tenon, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Bindi
authors.forename: B
authors.initials: B
authors.lastname: Mougenot
authors.forename: F
authors.initials: F
authors.lastname: Mentre
authors.forename: L H
authors.initials: LH
authors.lastname: Noel
authors.forename: M N
authors.initials: MN
authors.lastname: Peraldi
authors.forename: P
authors.initials: P
authors.lastname: Vanhille
authors.forename: P
authors.initials: P
authors.lastname: Lesavre
authors.forename: F
authors.initials: F
authors.lastname: Mignon
authors.forename: P M
authors.initials: PM
authors.lastname: Ronco
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies / Q000032:analysis; D002423:Cause of Death; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology / Q000401:mortality / Q000473:pathology*; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D009504:Neutrophils / Q000276:immunology; D011379:Prognosis; D051437:Renal Insufficiency / Q000209:etiology / Q000401:mortality / Q000473:pathology; D012307:Risk Factors
chemical_list: D000906:Antibodies